NASDAQ | TSX: ACB
EDMONTON, AB, Dec. 13, 2021 /CNW/ - Aurora Cannabis Inc. (the
"Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB),
the Canadian company defining the future of cannabinoids worldwide,
is pleased to acknowledge the Company's increased ranking in The
Globe and Mail's 2021 annual Report on Business review of Corporate
Boards, known as Board Games. As recognized in the 2021 Board Games
results, Aurora received 77 out of 100 eligible points, ranking
notably higher than others in its peer group of cannabis
companies.
For the 20th year in a row, Report on Business has
assessed the boards and governance practices of Canada's largest corporations within the
S&P/TSX Composite using a rigorous set of governance criteria
designed to go beyond minimum mandatory rules imposed by
regulators. Evaluated across four categories including Board
Composition, Shareholding and Compensation, Shareholder Rights, and
Disclosure, Aurora's 2021 score signifies a considerable
improvement from the previous years' results of 72 and 67 out
of 100 in 2020 and 2019, respectively.
Ronald Funk, Chairman of
Aurora stated, "With each passing year, Aurora continues to exhibit
growth and maturity across all areas of the business. Our improved
ranking in the 2021 Board Games report is a strong indication of
the progress we are making as an organization as we continue to
identify ways in which our policies and practices can better serve
our stakeholders. I am proud and honoured to be part of a Board
that stands out from its peers and demonstrates strength in
governance, strategic direction and accountability."
Aurora's 2021 Proxy Circular can be viewed here. For more
information on The Globe and Mail's Board Games methodology and to
view this year's comprehensive ranking of Canada's corporate boards, visit here.
About Aurora
Aurora is a global leader in the cannabis industry, serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis dedicated to helping people improve their lives.
The Company's brand portfolio includes Aurora, Aurora Drift, San
Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva
and KG7 CBD. Driven by science and innovation, and with a focus on
high-quality cannabis products, Aurora's brands continue to break
through as industry leaders in the medical, performance, wellness
and adult recreational markets wherever they are launched. Learn
more at http://www.auroramj.com/ and follow us on Twitter and
LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB" and is a constituent of the S&P/TSX Composite
Index.
Forward-looking Information
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements regarding
the Company's continuous improvements in governance related
matters.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news
release have been developed based on assumptions
management considers to be reasonable. Material factors or
assumptions involved in developing forward-looking statements
include, without limitation, publicly available information from
governmental sources as well as from market research and industry
analysis and on assumptions based on data and knowledge of this
industry which the Company believes to be reasonable.
Forward-looking statements are subject to a variety of
risks, uncertainties and other factors that management
believes to be relevant and reasonable in the circumstances could
cause actual events, results, level of activity, performance,
prospects, opportunities or achievements to differ materially from
those projected in the forward-looking statements. These risks
include, but are not limited to, the ability to retain key
personnel, the ability to continue investing in infrastructure to
support growth, the ability to obtain financing on acceptable
terms, the continued quality of our products, customer experience
and retention, the development of third party government and
non-government consumer sales channels, management's estimates of
consumer demand in Canada and in
jurisdictions where the Company exports, expectations of future
results and expenses, the risk of successful integration of
acquired business and operations, management's estimation that
SG&A will grow only in proportion of revenue growth, the
ability to expand and maintain distribution capabilities, the
impact of competition, the general impact of financial market
conditions, the yield from cannabis growing operations, product
demand, changes in prices of required commodities, competition, and
the possibility for changes in laws, rules, and regulations in the
industry, epidemics, pandemics or other public health crises,
including the current outbreak of COVID-19, and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 27, 2021 (the "AIF") and filed with
Canadian securities regulators available on the Company's issuer
profile on SEDAR at www.sedar.com and filed with and available on
the SEC's website at www.sec.gov. The Company cautions that the
list of risks, uncertainties and other factors described in the AIF
is not exhaustive and other factors could also adversely affect its
results. Readers are urged to consider the
risks, uncertainties and assumptions carefully in
evaluating the forward-looking statements and are cautioned not to
place undue reliance on such information. The Company is under no
obligation, and expressly disclaims any intention or obligation, to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except
as expressly required by applicable securities law.
SOURCE Aurora Cannabis Inc.